[1] Ramachandran SD, Vivarès A, Klieber S, et al.Applicability of second-generation upcyte human hepatocytes for use in CYP inhibition and induction studies[J]. Pharmacol Res Perspect, 2015, 3(5): e00161. [2] Betts S, Björkhem-Bergman L, Rane A, Expression of CYP3A4 and CYP3A7 in Human Foetal Tissues and its Correlation with Nuclear Receptors[J]. Basic Clin Pharmacol Toxicol, 2015,117(4):261-266. [3] Congiu M, Mashford ML, Slavin JL, et al.Coordinate regulation of metabolic enzymes and transporters by nuclear transcription factors in human liver disease[J]. J Gastroenterol Hepatol, 2009, 24(6): 1038-1044. [4] Fan L, Wang G, Wang LS, et al.Herbal medicine yin zhi huang induces CYP3A4-mediated sulfoxidation and CYP2C19-dependent hydroxylation of omeprazole[J].Acta Pharmacol Sin, 2007, 28(10): 1685-1692. [5] Lo YC, Lin YL, Yu KL, et al.San-Huang-Xie-Xin-Tang attenuates inflammatory responses in lipopolysaccharide-exposed rat lungs[J]. J Ethnopharmacol, 2005, 101(1-3):68-74. [6] 张建春,张华,施瑛,等.黄芩苷的研究近况[J].时珍国医国药,2005,16(3):247-249. [7] 谭宏祜. 关于茵栀黄、苦黄注射液等中药制剂在肝病临床的合理运用[J].中西医结合肝病杂志,2003,13(4):230. [8] Chiang JY.Bile acid regulation of gene expression: roles of nuclear hormone receptors[J].Endocr Rev, 2002, 23(4): 443-463. [9] 吴海滨,余世峰,兰绍阳.基于FXR探讨茵栀黄注射液利胆退黄的机制研究[J].辽宁中医杂志,2016,43(4):845-848. [10] 侯艳宁,程桂芳,朱秀媛.黄芩苷对小鼠肝细胞色素P450的选择性诱导[J].药学学报,2000,35(12):890-892. [11] Fan L, Wang JC, Jiang F, et al.Induction of cytochrome P450 2B6 activity by the herbal medicine baicalin as measured by bupropion hydroxylation[J]. Eur J Clin Pharmacol, 2009, 65(4): 403-409. |